New hope in fight against deadly brain-eating amoeba
On June 17, 2016, Cook Children's became the first hospital in Texas to carry Miltefosine, a drug that has shown success in treating Primary Amoebic Meningoencephalitis (PAM), the brain infection caused by the water-born amoeba, known as Naegleria fowleri. Until recently, Miltefosine was only available through the Centers for Disease Control and Prevention (CDC) and had to be shipped to hospitals on a patient-by-patient basis. Having Miltefosine on hand at Cook Children's means patients will not have to wait for a shipment to arrive, increasing their odds of survival. It also means quicker access to the drug for hospitals across Texas and the region.